{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:03:20Z","timestamp":1789441400925,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05903-8","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:24:06Z","timestamp":1789439046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pioglitazone protects against thioacetamide-induced liver fibrosis via AMPK-mediated inhibition of the TGF-\u03b2\/Smad fibrotic cascade"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5943-4631","authenticated-orcid":false,"given":"Omnia A.","family":"Hawary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Wadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin A. M.","family":"El-Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia F.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"5903_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.34172\/jhp.2023.21","volume":"12","author":"RF Abdel-Rahman","year":"2023","unstructured":"Abdel-Rahman RF, Fayed HM, Mohamed MA, Hessin AF, Asaad GF, AbdelRahman S et al (2023) Apigenin role against thioacetamide-triggered liver fibrosis: deciphering the PPAR\u03b3\/TGF-\u03b21\/NF-\u03baB and the HIF\/FAK\/AKT pathways. J Herbmed Pharmacol 12:202\u2013213. https:\/\/doi.org\/10.34172\/jhp.2023.21","journal-title":"J Herbmed Pharmacol"},{"key":"5903_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147873","volume":"25","author":"H Akk\u0131z","year":"2024","unstructured":"Akk\u0131z H, Gieseler RK, Canbay A (2024) Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells. Int J Mol Sci 25:7873. https:\/\/doi.org\/10.3390\/ijms25147873","journal-title":"Int J Mol Sci"},{"key":"5903_CR3","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s11756-022-01057-z","volume":"77","author":"A Akter","year":"2022","unstructured":"Akter A, Islam F, Bepary S, Al-Amin M, Begh MZ, Islam MA et al (2022) CNS depressant activities of Averrhoa carambola leaves extract in thiopental-sodium model of Swiss albino mice: implication for neuro-modulatory properties. Biologia (Bratisl) 77:1337\u20131346. https:\/\/doi.org\/10.1007\/s11756-022-01057-z","journal-title":"Biologia (Bratisl)"},{"key":"5903_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5223\/pghn.2020.23.4.346","volume":"23","author":"FS Alatas","year":"2020","unstructured":"Alatas FS, Matsuura T, Pudjiadi AH, Wijaya S, Taguchi T, Saito M et al (2020) Peroxisome proliferator-activated receptor gamma agonist attenuates liver fibrosis by several fibrogenic pathways in an animal model of cholestatic fibrosis. Pediatr Gastroenterol Hepatol Nutr 23:346\u2013355. https:\/\/doi.org\/10.5223\/pghn.2020.23.4.346","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"5903_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178493","volume":"26","author":"L Bader Eddin","year":"2025","unstructured":"Bader Eddin L, Mahgoub A, Almarzooqi S, Adeghate E, Subramanya SB, Ojha S (2025) \u03b2\u2011caryophyllene ameliorates thioacetamide\u2011induced liver fibrosis in rats: a preventative approach. Int J Mol Sci 26:8493. https:\/\/doi.org\/10.3390\/ijms26178493","journal-title":"Int J Mol Sci"},{"key":"5903_CR6","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41467-023-40081-8","volume":"14","author":"Y Bai","year":"2023","unstructured":"Bai Y, Li K, Li X, Chen X, Zheng J, Wu F et al (2023) Effects of oxidative stress on hepatic encephalopathy pathogenesis in mice. Nat Commun 14:4456. https:\/\/doi.org\/10.1038\/s41467-023-40081-8","journal-title":"Nat Commun"},{"key":"5903_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24:289\u2013293. https:\/\/doi.org\/10.1002\/hep.510240201","journal-title":"Hepatology"},{"key":"5903_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r1788","volume":"390","author":"K Bowie","year":"2025","unstructured":"Bowie K (2025) Semaglutide: FDA approves weight loss jab to treat severe liver disease. BMJ 390:r1788. https:\/\/doi.org\/10.1136\/bmj.r1788","journal-title":"BMJ"},{"key":"5903_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/w16020214","volume":"16","author":"B Brahmi","year":"2024","unstructured":"Brahmi B, Nasri E, Moula A, Feriani A, Tlili N, Raldua D et al (2024) Assessment of liver toxicity in Wistar rats after chronic exposure to phosphate-processing wastewaters from Gafsa-Metlaoui laundry in Tunisia. Water 16:214. https:\/\/doi.org\/10.3390\/w16020214","journal-title":"Water"},{"key":"5903_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12263-025-00784-7","volume":"20","author":"T Donia","year":"2025","unstructured":"Donia T, Elfeky DM, Bessa SS, Tousson E, Mohamed TM, Gerges MN (2025) The ameliorative effect of pioglitazone and\/or cod liver oil on hepatotoxicity induced by carbon tetrachloride in rats. Genes Nutr 20:25. https:\/\/doi.org\/10.1186\/s12263-025-00784-7","journal-title":"Genes Nutr"},{"key":"5903_CR11","first-page":"443","volume":"13","author":"HW El Gawly","year":"2009","unstructured":"El Gawly HW, Tawfik MK, Rashwan MF, Baruzaig AS (2009) The effect of pioglitazone on the liver of streptozotocin-induced diabetic albino wistar rats. Eur Rev Med Pharmacol Sci 13:443\u2013451","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5903_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11112152","volume":"11","author":"MA ElBaset","year":"2022","unstructured":"ElBaset MA, Salem RS, Ayman F, Ayman N, Shaban N, Afifi SM et al (2022) Effect of empagliflozin on thioacetamide-induced liver injury in rats: role of AMPK\/SIRT-1\/HIF-1\u03b1 pathway in halting liver fibrosis. Antioxidants (Basel) 11:2152. https:\/\/doi.org\/10.3390\/antiox11112152","journal-title":"Antioxidants (Basel)"},{"key":"5903_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.toxrep.2019.10.017","volume":"7","author":"FK El-Baz","year":"2020","unstructured":"El-Baz FK, Salama AA, Hussein RA (2020) Dunaliella salina microalgae oppose thioacetamide-induced hepatic fibrosis in rats. Toxicol Rep 7:36\u201345. https:\/\/doi.org\/10.1016\/j.toxrep.2019.10.017","journal-title":"Toxicol Rep"},{"key":"5903_CR14","doi-asserted-by":"publisher","unstructured":"ElGamal MM, Abdul-Kafy AL, Elbeltagi HM, Semary SES, AboSeif AM (2024) Comparative study of Hibiscus sabdariffa L. extract, pioglitazone, and simvastatin on NAFLD in a rat model. Int J Med Arts 6:4848\u20134856. \nhttps:\/\/doi.org\/10.21608\/ijma.2024.305865.2002","DOI":"10.21608\/ijma.2024.305865.2002"},{"key":"5903_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.taap.2017.06.012","volume":"329","author":"DM El-Tanbouly","year":"2017","unstructured":"El-Tanbouly DM, Wadie W, Sayed RH (2017) Modulation of TGF-\u03b2\/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice. Toxicol Appl Pharmacol 329:224\u2013230. https:\/\/doi.org\/10.1016\/j.taap.2017.06.012","journal-title":"Toxicol Appl Pharmacol"},{"key":"5903_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2841894","author":"N Enciso","year":"2022","unstructured":"Enciso N, Amiel J, Fabi\u00e1n-Dom\u00ednguez F, Pando J, Rojas N, Cisneros-Huaman\u00ed C et al (2022) Model of liver fibrosis induction by thioacetamide in rats for regenerative therapy studies. Anal Cell Pathol. https:\/\/doi.org\/10.1155\/2022\/2841894","journal-title":"Anal Cell Pathol"},{"key":"5903_CR17","doi-asserted-by":"publisher","first-page":"1558041","DOI":"10.3389\/fimmu.2025.1558041","volume":"16","author":"J Feng","year":"2025","unstructured":"Feng J, MengHuan L, TingTing Y, XueJie Y, HaiNing G (2025) Research progress on AMPK in the pathogenesis and treatment of MASLD. Front Immunol 16:1558041. https:\/\/doi.org\/10.3389\/fimmu.2025.1558041","journal-title":"Front Immunol"},{"key":"5903_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman SL, Pinzani M (2022) Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology 75:473\u2013488. https:\/\/doi.org\/10.1002\/hep.32285","journal-title":"Hepatology"},{"key":"5903_CR19","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1096\/fj.08-128736","volume":"23","author":"AK Ghosh","year":"2009","unstructured":"Ghosh AK, Bhattacharyya S, Wei J, Kim S, Barak Y, Mori Y et al (2009) Peroxisome proliferator-activated receptor-\u03b3 abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator. FASEB J 23:2968\u20132977","journal-title":"FASEB J"},{"key":"5903_CR20","doi-asserted-by":"publisher","unstructured":"Hawary OA, Wadie W, El-Said YA, Hassan OF (2025) Repurposing of semaglutide by targeting SIRT1 and TGF-\u03b2\/Smad signaling in hepatic fibrosis. Naunyn Schmiedebergs Arch Pharmacol\u00a02025:1\u201313. \nhttps:\/\/doi.org\/10.1007\/s00210-025-04675-x","DOI":"10.1007\/s00210-025-04675-x"},{"key":"5903_CR21","first-page":"192","volume":"15","author":"JB Jia","year":"2007","unstructured":"Jia JB, Liu Y, Chen WH, Liu M, Lu LG (2007) Effects of pioglitazone on the morphology and the expression of connective tissue growth factor of transforming growth factor beta-induced rat hepatic stellate cells in vitro. Zhonghua Gan Zang Bing Za Zhi 15:192\u2013195","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"5903_CR22","doi-asserted-by":"publisher","first-page":"8457","DOI":"10.1007\/s11033-023-08847-X","volume":"50","author":"GA Kamel","year":"2023","unstructured":"Kamel GA, Elariny HA (2023) Pioglitazone attenuates tamoxifen-induced liver damage in rats via modulation of Keap1\/Nrf2\/HO-1 signaling, reducing malondialdehyde and improving antioxidant status including GSH. Mol Biol Rep 50:8457\u20138466. https:\/\/doi.org\/10.1007\/s11033-023-08847-X","journal-title":"Mol Biol Rep"},{"key":"5903_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102029","volume":"45","author":"U Karunakaran","year":"2021","unstructured":"Karunakaran U, Elumalai S, Moon JS, Won KC (2021) Pioglitazone-induced AMPK-Glutaminase-1 prevents high glucose-induced pancreatic \u03b2-cell dysfunction by glutathione antioxidant system. Redox Biol 45:102029. https:\/\/doi.org\/10.1016\/j.redox.2021.102029","journal-title":"Redox Biol"},{"key":"5903_CR24","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.3390\/ijms26136022","volume":"26","author":"C Khongpiroon","year":"2025","unstructured":"Khongpiroon C, Buakaew W, Brindley PJ, Potikanond S, Daowtak K, Thongsri Y et al (2025) Effect of 3-hydroxy-\u03b2-ionone on liver fibrosis via the TGF-\u03b2\/Smad2\/3 signaling pathway. Int J Mol Sci 26:6022. https:\/\/doi.org\/10.3390\/ijms26136022","journal-title":"Int J Mol Sci"},{"key":"5903_CR25","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.7150\/ijbs.80743","volume":"19","author":"A Kundu","year":"2023","unstructured":"Kundu A, Gali S, Sharma S, Kacew S, Yoon S, Jeong HG et al (2023) Dendropanoxide alleviates thioacetamide-induced hepatic fibrosis via inhibition of ROS production and inflammation in BALB\/C mice. Int J Biol Sci 19:2630. https:\/\/doi.org\/10.7150\/ijbs.80743","journal-title":"Int J Biol Sci"},{"key":"5903_CR26","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3892\/ijo.2016.3627","volume":"49","author":"HS Lee","year":"2016","unstructured":"Lee HS, Shin HS, Choi J, Bae SJ, Wee HJ, Son T et al (2016) AMP-activated protein kinase activator, HL156A reduces thioacetamide-induced liver fibrosis in mice and inhibits the activation of cultured hepatic stellate cells and macrophages. Int J Oncol 49:1407\u20131414. https:\/\/doi.org\/10.3892\/ijo.2016.3627","journal-title":"Int J Oncol"},{"key":"5903_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1269747","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li Z, Liu T, Feng Y, Tong Y, Jia Y, Wang C et al (2022) PPAR\u03b3 alleviates sepsis\u2010induced liver injury by inhibiting hepatocyte pyroptosis via inhibition of the ROS\/TXNIP\/NLRP3 signaling pathway. Oxid Med Cell Longev 2022:1269747. https:\/\/doi.org\/10.1155\/2022\/1269747","journal-title":"Oxid Med Cell Longev"},{"key":"5903_CR28","doi-asserted-by":"publisher","unstructured":"Liu Y, Chen Y, Zhang X, Wang J, Li Q, Huang H et al (2021) Angiotensin II inhibits AMPK\/SIRT1 pathway by inducing oxidative stress in RAW264.7 macrophages. J South Med Univ 41:401\u20137. \nhttps:\/\/doi.org\/10.12122\/j.issn.1673-4254.2021.03.10","DOI":"10.12122\/j.issn.1673-4254.2021.03.10"},{"key":"5903_CR29","doi-asserted-by":"publisher","first-page":"G585","DOI":"10.1152\/ajpgi.00272.2025","volume":"329","author":"Y Lu","year":"2025","unstructured":"Lu Y, Oshins R, Maptue NR, Shen Q, Khemtong C, Cusi K et al (2025) Pioglitazone reduces hepatic \u03b1\u20111 antitrypsin accumulation through autophagy and AMPK activation in \u03b1\u20111 antitrypsin\u2011deficient mice. Am J Physiol Gastrointest Liver Physiol 329:G585\u2013G596. https:\/\/doi.org\/10.1152\/ajpgi.00272.2025","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5903_CR30","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3992","volume":"152","author":"Y Lu","year":"2021","unstructured":"Lu Y, Ye J, Wu Y, Wang Q, Tang X, He S et al (2021) Hepatoprotective effects of juglone on dimethylnitrosamine-induced liver fibrosis and modulation of PPAR-\u03b3, \u03b1-SMA, and collagen expression in rats. Food Chem Toxicol 152:112212. https:\/\/doi.org\/10.3892\/mmr.2015.3992","journal-title":"Food Chem Toxicol"},{"key":"5903_CR31","doi-asserted-by":"publisher","first-page":"1734449","DOI":"10.3389\/fphar.2025.1734449","volume":"16","author":"X Mao","year":"2025","unstructured":"Mao X, Chen Y, Zhou Z, Li Q, Zhang L, Liu J et al (2025) From mechanisms to anti-fibrotic drugs in hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives. Front Pharmacol 16:1734449. https:\/\/doi.org\/10.3389\/fphar.2025.1734449","journal-title":"Front Pharmacol"},{"key":"5903_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000235996","volume":"84","author":"J Mohapatra","year":"2009","unstructured":"Mohapatra J, Sharma M, Singh S, Chatterjee A, Swain P, Balaraman R et al (2009) Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db\/db mice. Pharmacology 84:203\u2013210. https:\/\/doi.org\/10.1159\/000235996","journal-title":"Pharmacology"},{"key":"5903_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158298","volume":"22","author":"HC Monroy-Ramirez","year":"2021","unstructured":"Monroy-Ramirez HC, Galicia-Moreno M, Sandoval-Rodriguez A, Meza-Rios A, Santos A, Armendariz-Borunda J (2021) PPARs as metabolic sensors and therapeutic targets in liver diseases. Int J Mol Sci 22:8298. https:\/\/doi.org\/10.3390\/ijms22158298","journal-title":"Int J Mol Sci"},{"key":"5903_CR34","doi-asserted-by":"publisher","unstructured":"Nathwani R, Mullish BH, Kockerling D, Forlano R, Manousou P, Dhar A (2020) A review of liver fibrosis and emerging therapies. Eur Med J Hepatol\u00a04:105\u201316. https:\/\/doi.org\/10.33590\/emj\/10310892","DOI":"10.33590\/emj\/10310892"},{"key":"5903_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13105-020-00777-7","volume":"77","author":"XX Ni","year":"2021","unstructured":"Ni XX, Li XY, Wang Q, Hua J (2021) Regulation of peroxisome proliferator-activated receptor-gamma activity affects hepatic stellate cell activation and the progression of NASH via TGF-\u03b21\/Smad signaling pathway. J Physiol Biochem 77:35\u201345. https:\/\/doi.org\/10.1007\/s13105-020-00777-7","journal-title":"J Physiol Biochem"},{"key":"5903_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/biology11050739","volume":"11","author":"HA Ogaly","year":"2022","unstructured":"Ogaly HA, Aldulmani SAA, Al-Zahrani FAM, Abd-Elsalam RM (2022) D-Carvone attenuates CCl\u2084-induced liver fibrosis in rats: histopathological assessment using hematoxylin and eosin and Masson\u2019s trichrome staining. Biology (Basel) 11:739. https:\/\/doi.org\/10.3390\/biology11050739","journal-title":"Biology (Basel)"},{"key":"5903_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23694","volume":"38","author":"S Raghunandhakumar","year":"2024","unstructured":"Raghunandhakumar S, Ezhilarasan D, Shree Harini K (2024) Thymoquinone protects thioacetamide\u2010induced chronic liver injury by inhibiting TGF\u2010\u03b21\/Smad3 axis in rats. J Biochem Mol Toxicol 38:e23694. https:\/\/doi.org\/10.1002\/jbt.23694","journal-title":"J Biochem Mol Toxicol"},{"key":"5903_CR38","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jceh.2021.11.004","volume":"12","author":"P Sharma","year":"2022","unstructured":"Sharma P (2022) Value of liver function tests in cirrhosis. J Clin Exp Hepatol 12:948\u2013964. https:\/\/doi.org\/10.1016\/j.jceh.2021.11.004","journal-title":"J Clin Exp Hepatol"},{"key":"5903_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55764-5","volume":"14","author":"MH Shihan","year":"2024","unstructured":"Shihan MH, Sharma S, Cable C, Prathigudupu V, Chen A, Mattis AN et al (2024) AMPK stimulation inhibits YAP\/TAZ signaling to ameliorate hepatic fibrosis. Sci Rep 14:5205. https:\/\/doi.org\/10.1038\/s41598-024-55764-5","journal-title":"Sci Rep"},{"key":"5903_CR40","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1161\/01.CIR.0000039346.31538.2C","volume":"106","author":"T Shiomi","year":"2002","unstructured":"Shiomi T, Tsutsui H, Hayashidani S, Suematsu N, Ikeuchi M, Wen J et al (2002) Pioglitazone, a peroxisome proliferator\u2013activated receptor-\u03b3 agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 106:3126\u20133132. https:\/\/doi.org\/10.1161\/01.CIR.0000039346.31538.2C","journal-title":"Circulation"},{"key":"5903_CR41","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14286","volume":"7","author":"A Tahara","year":"2019","unstructured":"Tahara A, Takasu T (2019) SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone prevents progression of nonalcoholic steatohepatitis in a type 2 diabetes rodent model. Physiol Rep 7:14286. https:\/\/doi.org\/10.14814\/phy2.14286","journal-title":"Physiol Rep"},{"key":"5903_CR42","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1097\/MS9.0000000000002770","volume":"87","author":"A Waheed","year":"2025","unstructured":"Waheed A, Gul MH, Shabbir MU, Raja HA, Wardak AB, Hussaini H et al (2025) FDA approves Resmetirom: groundbreaking treatment for NASH liver scarring in moderate to advanced fibrosis. Ann Med Surg (Lond) 87:1088\u20131091. https:\/\/doi.org\/10.1097\/MS9.0000000000002770","journal-title":"Ann Med Surg (Lond)"},{"key":"5903_CR43","doi-asserted-by":"publisher","first-page":"82864","DOI":"10.18632\/oncotarget.12655","volume":"7","author":"H Wang","year":"2016","unstructured":"Wang H, Zhang H, Zhang Y, Wang D, Cheng X, Yang F et al (2016) Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget 7:82864\u201382875. https:\/\/doi.org\/10.18632\/oncotarget.12655","journal-title":"Oncotarget"},{"key":"5903_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1111430","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Du H, Zhao Y, Ren Y, Ma C, Chen H et al (2023) Response to pioglitazone in non\u2011alcoholic fatty liver disease patients with vs. without type 2 diabetes: a meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne) 14:1111430. https:\/\/doi.org\/10.3389\/fendo.2023.1111430","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5903_CR45","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3748\/wjg.v10.i7.1047","volume":"10","author":"GJ Yuan","year":"2004","unstructured":"Yuan GJ, Zhang ML, Gong ZJ (2004) Effects of PPAR\u03b3 agonist pioglitazone on rat hepatic fibrosis. World J Gastroenterol 10:1047","journal-title":"World J Gastroenterol"},{"key":"5903_CR46","doi-asserted-by":"publisher","first-page":"16278","DOI":"10.1038\/s41598-024-67102-w","volume":"14","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Guo J, Shi C, Zhang D, Wang Y, Wang L et al (2024a) The SIRT2-AMPK axis regulates autophagy induced by acute liver failure. Sci Rep 14:16278. https:\/\/doi.org\/10.1038\/s41598-024-67102-w","journal-title":"Sci Rep"},{"key":"5903_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2478\/fzm-2024-0002","volume":"4","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhao W, Sun Z, Dong X, Zhu L, Zhang Z et al (2024b) Peroxisome proliferator-activated receptor gamma ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-\u03b2\/Smad signaling activation. Frigid Zone Med 4:12\u201322","journal-title":"Frigid Zone Med"},{"key":"5903_CR48","doi-asserted-by":"publisher","first-page":"1454980","DOI":"10.3389\/fmed.2024.1454980","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ren L, Tian Y, Guo X, Wei F, Zhang Y et al (2024c) Signaling pathways that activate hepatic stellate cells during liver fibrosis. Front Med (Lausanne) 11:1454980. https:\/\/doi.org\/10.3389\/fmed.2024.1454980","journal-title":"Front Med (Lausanne)"},{"key":"5903_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110770","volume":"203","author":"AR Zhao","year":"2023","unstructured":"Zhao AR, Li J, Wang SQ, Bian LH, Li WJ, Guo JY (2023) Stress can affect mitochondrial energy metabolism and AMPK\/SIRT1 signaling pathway in rats. Brain Res Bull 203:110770. https:\/\/doi.org\/10.1016\/j.brainresbull.2023.110770","journal-title":"Brain Res Bull"},{"key":"5903_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.783886","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Liu X, Ding C, Gu Y, Liu W (2021) Dihydromyricetin reverses thioacetamide-induced liver fibrosis through inhibiting NF-\u03baB-mediated inflammation and TGF-\u03b21-regulated of PI3K\/Akt signaling pathway. Front Pharmacol 12:783886. https:\/\/doi.org\/10.3389\/fphar.2021.783886","journal-title":"Front Pharmacol"},{"key":"5903_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-025-02359-w","volume":"23","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Li X, Liu J, Wang Y, Chen Z, Zhang L et al (2025) Role of adiponectin and its receptors AdipoR1\/2 in energy homeostasis and metabolic signaling: involvement of PPAR-\u03b3 and downstream AMPK pathways. Cell Commun Signal 23:59. https:\/\/doi.org\/10.1186\/s12964-025-02359-w","journal-title":"Cell Commun Signal"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05903-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05903-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05903-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:24:08Z","timestamp":1789439048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05903-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":51,"alternative-id":["5903"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05903-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}